A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response

Gros, L., Paturel, C., Perrot, I., Bensussan, A., Eliaou, J. F., Bastid, J., & Bonnefoy, N. (2020). A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response. Medecine/Sciences, 36(2), 112–115. https://doi.org/10.1051/medsci/2020006